Stereotactic Radiotherapy in Combination with the Immunoconjugate Trastuzumab Emtansine in Patients with HER2-Positive Oligometastatic Breast Cancer: Final Results of the Efficacy and Safety Study. Voprosy onkologii, v. 72, n. 3, p. OF-2696, 3 Jul.2026.